Atlas Trials

International Sites: Novel Experimental COVID-19 Therapies Affecting Host Response

Clinical trial NCT05593770 · TERMINATED

Trial details

NCT number
NCT05593770
Sponsor
NEAT ID Foundation
Status
TERMINATED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
COVID-19SARS-CoV2 InfectionCoronavirus Infection
Start date
2022-10-27
Primary completion
2023-12-14
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.